🔗 Permalink

Inventor profile of:

Stephen Wright

City:

Cambridge

Country:

United Kingdom

Published Applications:

Last publication date:

2025-12-25

Top Assignees for applications by Stephen Wright

The entities that hold a legal rights for patent applications filed by inventor Wright Stephen:

GW Research Limited 14 Cambridge, United Kingdom
GW Pharma Limited 3 Cambridge, United Kingdom
OTSUKA PHARMACEUTICAL CO., LIMITED 1 Tokyo, Japan
GW Pharma Limited 1 Salisbury, United Kingdom
Jazz Pharmaceuticals Research UK Limited 1 Sittingbourne, United Kingdom
Jazz Pharmaceuticals Research UK Limited 1 Kent, United Kingdom
GW Research Limited 1 Histon, United Kingdom
GW Pharma Limited 1 Vision Park, Histon, Cambridge, -

Recent patent applications by Wright Stephen

Stephen Wright from Cambridge, GB has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-12-25

US20250387418A1

Human necessities

USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY

#2 | 2024-02-01

US20240033229A1

Human necessities

USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY

#3 | 2023-08-24

US20230263744A1

Human necessities

USE OF CANNABINOIDS IN THE TREATMENT OF ANGELMAN SYNDROME

#4 | 2022-12-01

US20220378717A1

Human necessities

Use of cannabinoids in the treatment of epilepsy

#5 | 2022-06-30

US20220202738A1

Human necessities

CANNABINOIDS IN THE TREATMENT OF EPILEPSY

#6 | 2022-03-31

US20220096397A1

Human necessities

Parenteral formulations

#7 | 2021-12-30

US20210401771A1

Human necessities

Use of cannabinoids in the treatment of epilepsy

#8 | 2021-10-07

US20210308072A1

Human necessities

Combination of cannabinoids in the treatment of leukemia

#9 | 2021-09-23

US20210290565A1

Human necessities

Use of cannabidiol in the treatment of epilepsy

#10 | 2021-07-08

US20210205262A1

Human necessities

Use of cannabidiolic acid in the treatment of autism spectrum disorder and associated disorders

#11 | 2021-05-20

US20210145765A1

Human necessities

Use of cannabidiol in the treatment of epilepsy

#12 | 2021-04-01

US20210093581A1

Human necessities

Use of cannabinoids in the treatment of epilepsy

#13 | 2021-03-04

US20210059959A1

Human necessities

USE OF CANNABINOIDS IN THE TREATMENT OF MENTAL DISORDERS

#14 | 2020-11-26

US20200368179A1

Human necessities

USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY

#15 | 2020-06-11

US20200179303A1

Human necessities

USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY

#16 | 2020-05-07

US20200138738A1

Human necessities

USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY

#17 | 2019-12-05

US20190365667A1

Human necessities

Oral cannabinoid formulations

#18 | 2019-10-24

US20190321307A1

Human necessities

Use of cannabinoids in the treatment of Angelman syndrome

#19 | 2019-05-30

US20190160023A1

Human necessities

Use of cannabidivarin in the treatment of autism spectrum disorder, associated disorders and schizophrenia

#20 | 2019-04-25

US20190117619A1

Human necessities

Use of cannabidiolic acid in the treatment of autism spectrum disorder and associated disorders

#21 | 2019-03-21

US20190083418A1

Human necessities

Use of cannabinoids in the treatment of epilepsy

#22 | 2019-03-07

US20190070128A1

Human necessities

USE OF CANNABIDIVARIN IN THE TREATMENT OF AUTISM SPECTRUM DISORDER, ASSOCIATED DISORDERS AND SCHIZOPHRENIA

#23 | 2018-02-15

US20180042975A1

Human necessities

PHYTOCANNABINOIDS IN THE TREATMENT OF CANCER

#24 | 2017-08-31

US20170246121A1

Human necessities

Use of cannabinoids in the treatment of epilepsy

#25 | 2017-08-24

US20170239193A1

Human necessities

USE OF CANNABIDIOL IN THE TREATMENT OF NOCTURNAL SNORING

#26 | 2017-08-17

US20170231923A1

Human necessities

Use of cannabidiol in the treatment of epilepsy

#27 | 2017-01-12

US20170007551A1

Human necessities

Use of cannabinoids in the treatment of epilepsy

#28 | 2016-06-16

US20160166515A1

Human necessities

Use of cannabinoids in the treatment of epilepsy

#29 | 2016-06-16

US20160166514A1

Human necessities

Use of cannabidiol in the treatment of epilepsy

#30 | 2015-12-17

US20150359756A1

Human necessities

Use of cannabinoids in the treatment of epilepsy

#31 | 2015-12-17

US20150359755A1

Human necessities

Use of cannabinoids in the treatment of epilepsy

InventorID:

1390606 ⎘